68 related articles for article (PubMed ID: 24927395)
1. A novel Affibody bioconjugate for dual-modality imaging of ovarian cancer.
Wang Y; Miao Z; Ren G; Xu Y; Cheng Z
Chem Commun (Camb); 2014 Nov; 50(85):12832-5. PubMed ID: 24927395
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of four affibody-based near-infrared fluorescent probes for optical imaging of epidermal growth factor receptor positive tumors.
Qi S; Miao Z; Liu H; Xu Y; Feng Y; Cheng Z
Bioconjug Chem; 2012 Jun; 23(6):1149-56. PubMed ID: 22621238
[TBL] [Abstract][Full Text] [Related]
3. Preparation and preliminary evaluation of a biotin-targeted, lectin-targeted dendrimer-based probe for dual-modality magnetic resonance and fluorescence imaging.
Xu H; Regino CA; Koyama Y; Hama Y; Gunn AJ; Bernardo M; Kobayashi H; Choyke PL; Brechbiel MW
Bioconjug Chem; 2007; 18(5):1474-82. PubMed ID: 17711320
[TBL] [Abstract][Full Text] [Related]
4. Cellular imaging using biocompatible dendrimer-functionalized graphene oxide-based fluorescent probe anchored with magnetic nanoparticles.
Wate PS; Banerjee SS; Jalota-Badhwar A; Mascarenhas RR; Zope KR; Khandare J; Misra RD
Nanotechnology; 2012 Oct; 23(41):415101. PubMed ID: 23010805
[TBL] [Abstract][Full Text] [Related]
5. NIRF Optical/PET Dual-Modal Imaging of Hepatocellular Carcinoma Using Heptamethine Carbocyanine Dye.
Zhang C; Zhao Y; Zhao N; Tan D; Zhang H; Chen X; Zhang H; An J; Shi C; Li M
Contrast Media Mol Imaging; 2018; 2018():4979746. PubMed ID: 29706843
[TBL] [Abstract][Full Text] [Related]
6. Efficient construction of PET/fluorescence probe based on sarcophagine cage: an opportunity to integrate diagnosis with treatment.
Liu S; Li D; Huang CW; Yap LP; Park R; Shan H; Li Z; Conti PS
Mol Imaging Biol; 2012 Dec; 14(6):718-24. PubMed ID: 22476968
[TBL] [Abstract][Full Text] [Related]
7. Chemoenzymatic strategy for the synthesis of site-specifically labeled immunoconjugates for multimodal PET and optical imaging.
Zeglis BM; Davis CB; Abdel-Atti D; Carlin SD; Chen A; Aggeler R; Agnew BJ; Lewis JS
Bioconjug Chem; 2014 Dec; 25(12):2123-8. PubMed ID: 25418333
[TBL] [Abstract][Full Text] [Related]
8. Bio-imaging and cancer targeting with glycoproteins and N-glycans.
Fukase K; Tanaka K
Curr Opin Chem Biol; 2012 Dec; 16(5-6):614-21. PubMed ID: 23176972
[TBL] [Abstract][Full Text] [Related]
9. An iron(III) selective dendrite chelator based on polyamidoamine dendrimer modified with 4-bromo-1,8-naphthalimide.
Grabchev I; Chovelon JM; Petkov C
Spectrochim Acta A Mol Biomol Spectrosc; 2008 Jan; 69(1):100-4. PubMed ID: 17451996
[TBL] [Abstract][Full Text] [Related]
10. Construction of specific magnetic resonance imaging/optical dual-modality molecular probe used for imaging angiogenesis of gastric cancer.
Yan X; Song X; Wang Z
Artif Cells Nanomed Biotechnol; 2017 May; 45(3):399-403. PubMed ID: 27074993
[TBL] [Abstract][Full Text] [Related]
11. Anti-Her-2 monoclonal antibody conjugated polymer fluorescent nanoparticles probe for ovarian cancer imaging.
Hun X; Zhang Z; Tiao L
Anal Chim Acta; 2008 Sep; 625(2):201-6. PubMed ID: 18724995
[TBL] [Abstract][Full Text] [Related]
12. HER-2/neu targeted delivery of a nanoprobe enables dual photoacoustic and fluorescence tomography of ovarian cancer.
Xi L; Satpathy M; Zhao Q; Qian W; Yang L; Jiang H
Nanomedicine; 2014 Apr; 10(3):669-77. PubMed ID: 24269306
[TBL] [Abstract][Full Text] [Related]
13. Dynamic fluorescent imaging with the activatable probe, γ-glutamyl hydroxymethyl rhodamine green in the detection of peritoneal cancer metastases: Overcoming the problem of dilution when using a sprayable optical probe.
Nakamura Y; Harada T; Nagaya T; Sato K; Okuyama S; Choyke PL; Kobayashi H
Oncotarget; 2016 Aug; 7(32):51124-51137. PubMed ID: 27286461
[TBL] [Abstract][Full Text] [Related]
14. Hybridization-based aptamer labeling using complementary oligonucleotide platform for PET and optical imaging.
Park JY; Lee TS; Song IH; Cho YL; Chae JR; Yun M; Kang H; Lee JH; Lim JH; Cho WG; Kang WJ
Biomaterials; 2016 Sep; 100():143-51. PubMed ID: 27258484
[TBL] [Abstract][Full Text] [Related]
15. A Nile blue based infrared fluorescent probe: imaging tumors that over-express cyclooxygenase-2.
Wang B; Fan J; Wang X; Zhu H; Wang J; Mu H; Peng X
Chem Commun (Camb); 2015 Jan; 51(4):792-5. PubMed ID: 25424129
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of anionic half generation 3.5-6.5 poly(amidoamine) dendrimers as delivery vehicles for the active component of the anticancer drug cisplatin.
Kirkpatrick GJ; Plumb JA; Sutcliffe OB; Flint DJ; Wheate NJ
J Inorg Biochem; 2011 Sep; 105(9):1115-22. PubMed ID: 21704583
[TBL] [Abstract][Full Text] [Related]
17. Novel Strategy for Preparing Dual-Modality Optical/PET Imaging Probes via Photo-Click Chemistry.
Sun L; Ding J; Xing W; Gai Y; Sheng J; Zeng D
Bioconjug Chem; 2016 May; 27(5):1200-4. PubMed ID: 27098544
[TBL] [Abstract][Full Text] [Related]
18. PAMAM structure-based multifunctional fluorescent conjugates for improved fluorescent labelling of biomacromolecules.
Wängler C; Moldenhauer G; Saffrich R; Knapp EM; Beijer B; Schnölzer M; Wängler B; Eisenhut M; Haberkorn U; Mier W
Chemistry; 2008; 14(27):8116-30. PubMed ID: 18752247
[TBL] [Abstract][Full Text] [Related]
19. Peptide-conjugated polyamidoamine dendrimer as a nanoscale tumor-targeted T1 magnetic resonance imaging contrast agent.
Han L; Li J; Huang S; Huang R; Liu S; Hu X; Yi P; Shan D; Wang X; Lei H; Jiang C
Biomaterials; 2011 Apr; 32(11):2989-98. PubMed ID: 21277017
[TBL] [Abstract][Full Text] [Related]
20. Site-Specific, Platform-Based Conjugation Strategy for the Synthesis of Dual-Labeled Immunoconjugates for Bimodal PET/NIRF Imaging of HER2-Positive Tumors.
Adumeau P; Raavé R; Boswinkel M; Heskamp S; Wessels HJCT; van Gool AJ; Moreau M; Bernhard C; Da Costa L; Goncalves V; Denat F
Bioconjug Chem; 2022 Mar; 33(3):530-540. PubMed ID: 35230093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
